Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively

Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business

The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23

St. George’s University School of Medicine to host a webinar for aspiring doctors

The students can interact with resident doctors and graduates of SGU

Shalby commences pre-registration for kids' covid vaccine

The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities

Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics

Both parties are expected to invest a total of US $ 1 million to establish the brand

Mandaviya launches the sixth edition of National Formulary of India (NFI)

The NFI is published to promote the rational use of medicines in the country.

Transforming Healthcare Through AI

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.

Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah

Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications